Last reviewed · How we verify
NCT05354739
Comparing Buzzy Device With Emla Cream in Needle Related Pain
trial testing The vibration cold device (BUZZY) in Procedural Pain in 300 participants. Completed in 29 September 2021.
29 September 2021
Quick facts
| Lead sponsor | Hamad Medical Corporation |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 2 February 2021 |
| Primary completion | 29 September 2021 |
| Estimated completion | 29 September 2021 |
| Sites | 1 location across Qatar |
Drugs / interventions tested
- The vibration cold device (BUZZY)
Conditions studied
- Procedural Pain — all drugs for Procedural Pain →
Sponsor
Hamad Medical Corporation — full company profile →
Who can join
Adults 2 to 14, any sex, with Procedural Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This randomized controlled study will enroll the eligible patients to either the Buzzy device arm or to the EMLA cream arm as a standard therapy. This will be done with concealment; however, blinding will not be practical. Will include 300 participants with 150 in each arm in Al Saad pediatric emergency. The research nurse will use a known valid and reliable measurements scales for the pain and anxiety. The data will be recorded with timing in a prepared form, The SPSS 22.0 and Epi-info soft wares and appropriate statistical tests will be used and will consider P value of \<0.05 is statistically significant. The investigators are anticipating a Buzzy device effectiveness to be not less than the EMLA cream but the rapidity of effectiveness in buzzy device of around one minute compared to 30-45 minutes of EMLA cream will be an important outcome in a busy emergency department.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Efficacy of Buzzy Device Versus EMLA Cream for Reducing Pain During Needle-Related Procedures in Children: A Randomized Controlled Trial.
Haidar NA, Al Amri MH, Sendad NG, Toaimah FHS. · · 2024 · cited 6× · PMID 37163686 · DOI 10.1097/pec.0000000000002965
Verify or expand the search:
- PubMed search for NCT05354739
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Procedural Pain
Currently open trials in the same condition.
- NCT07512791 — Effect of Bagua Auriculotherapy on Pain in Patients Undergoing Hysteroscopy · NA · active not recruiting
- NCT07094451 — Virtual Reality for Pain Control in US-Guided Obstetric Needle Procedures · NA · recruiting
- NCT06913270 — Virtual Reality Adjunct for Procedural Pain and Anxiety Management in Burn Wound Care · NA · recruiting
- NCT07440342 — TEAS for Sedation During ERCP: A Multicenter Trial · NA · recruiting
- NCT06346171 — VR Augmented Human Delivered Integrative Psychotherapy for Colonoscopy Procedural Anxiety and Pain · NA · active not recruiting
Other Hamad Medical Corporation trials
Trials by the same sponsor.
- NCT07333209 — Scheduled Positioning With a Peanutball(SPP) on Labor Outcomes Among Primiparous Women Under Epidural Analgesia · NA · recruiting
- NCT07270939 — Optimizing Enteral Nutrition Regimen for Critically Ill Patients · NA · not yet recruiting
- NCT07307508 — Efficacy of Scalp Block in Managing Post Subarachnoid Hemorrhage Headache in Critically Ill Patients. A Single Centre Ra · NA · recruiting
- NCT06622577 — The Effect of Dietary Management and Cysteine Supplementation on Growth Parameters and Biochemical Control for Pediatric · NA · not yet recruiting
- NCT06887855 — Enhancing Post-Stroke Dysphagia Rehabilitation · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05354739 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hamad Medical Corporation
- Last refreshed: 29 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05354739.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing